Barings’s Sabra Healthcare REIT SBRA Stock Holding History

Barings’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,266,769	Closed	-$29.3M	–	750
2018 Q3	$29.3M	Buy	1,266,769 +357,290	+39%	+$8.09M	0.41%	37
2018 Q2	$19.8M	Buy	+909,479	New	+$17.8M	0.28%	61

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Barings's SBRA Position: Q4 2018 in Review

Barings sold out of Sabra Healthcare REIT (SBRA) in Q4 2018, closing a stake of 1,266,769 shares — an estimated $29.3M sold.

Barings first reported a position in SBRA in Q2 2018 and held it in 2 quarters. The position peaked at $29.3M in Q3 2018. 362 funds tracked by Wall St. Rank hold SBRA as of Q4 2018.

Barings reported no remaining Sabra Healthcare REIT position as of Q4 2018 after selling out during the quarter.
Barings sold 1,266,769 Sabra Healthcare REIT shares in Q4 2018, an estimated $29.3M.
Barings first reported a position in Sabra Healthcare REIT in Q2 2018 and held it in 2 quarters.
Barings's Sabra Healthcare REIT position peaked at $29.3M in Q3 2018.
362 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2018.

Based on Barings's 13F filing for Q4 2018, filed 7 Feb 2019.